Theravance Biopharma (TBPH) Other Non-Current Liabilities (2013 - 2026)
Theravance Biopharma (TBPH) reported Other Non-Current Liabilities of $244,000 for Q2 2026, down 84.2% from $1.55 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Theravance Biopharma posted Other Non-Current Liabilities of $313,000, down 83.4% from FY2024.
- Other Non-Current Liabilities has a five-year compound annual growth rate of -29.8% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $1.89 million in FY2024 (-68.1%), $5.92 million in FY2023 (+257.2%), $1.66 million in FY2022 (-24.0%) and $2.18 million in FY2021 (+18.9%).
- Five-year quarterly Other Non-Current Liabilities spans a low of $244,000 in Q1 2026 and a high of $7.68 million in Q3 2023.
- Year over year, Other Non-Current Liabilities has now declined in each of the last ten quarters, with an average decline of 73.8% over the last eight quarters.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q3 2023 (growth of 363.4%); the low point was Q3 2025 (a decline of 93.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $244,000 (Q1 2026), $313,000 (Q4 2025) and $313,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 244,000.00 |
| Mar 31, 2026 | 244,000.00 |
| Dec 31, 2025 | 313,000.00 |
| Sep 30, 2025 | 313,000.00 |
| Jun 30, 2025 | 1.55 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Sep 30, 2024 | 4.98 Mn |
| Jun 30, 2024 | 4.89 Mn |
| Mar 31, 2024 | 5.45 Mn |
| Dec 31, 2023 | 5.92 Mn |
| Sep 30, 2023 | 7.68 Mn |
| Jun 30, 2023 | 7.68 Mn |
| Mar 31, 2023 | 7.68 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 1.66 Mn |
| Jun 30, 2022 | 2.40 Mn |
| Mar 31, 2022 | 2.43 Mn |
| Dec 31, 2021 | 2.18 Mn |
| Sep 30, 2021 | 2.61 Mn |
API Access
Theravance Biopharma Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();